- Release Date: 20/02/23 09:41
- Summary: Recce Selects CMAX for Phase I/II UTI Clinical Trial
- Price Sensitive: Yes
- Download Document 393.65KB
- Forums
- ASX - By Stock
- RCE
- Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial
Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.5¢ |
Change
0.025(4.72%) |
Mkt cap ! $113.2M |
Open | High | Low | Value | Volume |
55.0¢ | 55.5¢ | 55.0¢ | $10.72K | 19.50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49514 | 53.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.0¢ | 13000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49514 | 0.530 |
2 | 1100 | 0.520 |
1 | 40000 | 0.505 |
3 | 48000 | 0.500 |
1 | 50000 | 0.495 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 13000 | 2 |
0.580 | 5000 | 1 |
0.595 | 66989 | 3 |
0.600 | 214144 | 5 |
0.605 | 2000 | 1 |
Last trade - 15.57pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
54.8¢ |
  |
Change
0.025 ( 1.26 %) |
|||
Open | High | Low | Volume | ||
54.8¢ | 54.8¢ | 54.8¢ | 490 | ||
Last updated 15.05pm 12/06/2024 ? |
Featured News
RCE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online